Who are Neotis's investors?

Neotis's investors include Daphni.

Neotis

1 known investors

Neotis develops immunotherapies to counteract age-related tissue decline by directing the immune system, with an initial focus on fibrotic disease. The company combines expertise in immunology, senescence, and biomarker development.

AI & Machine Learning Biotech Deep Tech Longevity Medical Devices

Founders & leadership

Cathal Meehan, PhDCEO

Michael Saitakis, PhDCSO

Investors · 1

DaphniParis · $540K – $6.5M

Competitors · 1

by search overlap

Fortis Life Sciences3 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.

Companies competing with Neotis for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

10 of Europe’s largest 2026 VC funds, so far | EU-Startupseu-startups.com · Jul 2026

Frequently asked questions

What does Neotis do?: Neotis develops immunotherapies to counteract age-related tissue decline by directing the immune system, with an initial focus on fibrotic disease. The company combines expertise in immunology, senescence, and biomarker development.
Who are Neotis's investors?: Neotis's investors include Daphni.